Australia is closely awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://saulusvi956353.national-wiki.com/2584719/this_new_drug_retatrutide_australia_a_new_solution_for_weight_management